학술논문
627P Real-world evidence (RWE) for patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with cabazitaxel (CBZ): Comparison with the randomized clinical study CARD
Document Type
Abstract
Author
Source
In Annals of Oncology September 2020 31 Supplement 4:S518-S518
Subject
Language
ISSN
0923-7534